Sphere Fluidics

Encapsulating Biology Transforming Discovery

Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge, already with  25 developed and patented products – biochips and specialist chemicals – which are assisting over 220 customers globally with their research. 

Sphere Fluidics initially focussed on producing novel biochip systems and providing R&D services, but have since extended their expertise and are now developing a technology platform that enables discovery in a range of growing markets through single cell analysis. The systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, enhance research efficiency and will offer exciting benefits to those working in diagnostics and therapeutics.